baber/WOPTO huggingface dataset:
Patent SG-44165-A1 (SG)
Title: Improved method for the rolling of long products and rolling line which performs that method
Inventor: LESTANI MASSIMO
IPC: B21B45/02
Filed: 1997-02-06
Abstract: Improved method for the rolling of long products in a line comprising in sequence at least one roughing assembly (11), a possible reduction/sizing assembly (19) with three rolling passes, a fast pre-finishing block (25) and a fast finishing assembly (31), the method being suitable to roll products starting with a nominal size of section between 120 and 180 mm., the products of the range of dimensions between 20 mm. and 25 mm. being finished in a reduction/sizing assembly (19) with three rolling passes positioned upstream of the fast pre-finishing block (25), the relative changes of products being concentrated in the reduction/sizing assembly (19), the whole range of dimensions of the products between 4.0 mm. and 20 mm. being subjected to the same reduction sequence up to last rolling pass of the fast pre-finishing block (25), the changes of products being carried out only in the rolling passes of the fast finishing assembly (31), the temperature of a bar entering the fast finishing assembly (31) being about 700 to 750 DEG C., in which method the bar upstream of the fast finishing assembly (31) is subjected to a cooling with water at a low pressure of about 6 bar such as will prevent the initiation of vibrations at the point of the bar travelling through the cooling line. Improved rolling line for long products which comprises at least one roughing assembly (11), a fast pre-finishing block (25) and a fast finishing assembly (31), the line being suitable to roll products starting with a nominal size of section between 120 and 180 mm., two pairs of cantilever rolling blocks (13) with rolling stands having alternate horizontal/vertical axes being included between the roughing assembly (11) and the fast pre-finishing block (25) and being followed by a reduction/sizing assembly (19) with three rolling passes having the function of finishing the products in the range between 20 mm. and 25 mm., the fast finishing assembly (31) having four rolling passes and comprising two separate modules, each having two rolling passes, in which line at least the fast finishing assembly (31) and/or the reduction/sizing assembly (19) with three rolling passes are associated with an assembly (218, 118) performing the fast change of equipment according to the required reduction. <IMAGE>
Patent SG-165136-A1 (SG)
Title: Recombinant molecules and uses therefor
Inventor: ENG KHOO HOON
Filed: 1999-12-28
Abstract: The present invention provides a recombinant polypeptide encoding a hyaluronidase from the venom gland of an aquatic animal, preferably stonefish, or a biologically active fragment of said polypeptide, or a variant or derivative of these, said recombinant polypeptide comprising the sequence set forth in SEQ ID NO: 6, with the proviso that said biologically active fragment does not consist of the sequence set forth in SEQ ID NO: 9. The invention also provides a polynucleotide encoding the recombinant polypeptide, biologically active fragment, variant or derivative, expression vectors and host cells containing such polynucleotide. The invention is further directed to expression of such polynucleotide to produce the recombinant polypeptide of the invention, or a recombinant biologiclaly active fragment thereof, or variant or derivatives of these. Such recombinant products are useful in the preparation of compositions for enhancing fertilisation of mammalian eggs and other possible therapeutic uses. (Figure 2 is to be published)
Patent SG-141252-A1 (SG)
Title: A cuff link
Inventor: HUSSAIN SHAHNAWAZ
Filed: 2006-09-08
Abstract: A CUFF LINK A cuff link (1) for use in releasably coupling first and second sections (5a,5b) of a sleeve together, said cuff link (1) including first and second retaining members (2a,2b) having respective first and second attachment surfaces that are attached to opposing ends of a bridging member (3), wherein the first retaining member (2a) is releasably attachable to the bridging member (3), such that when the first retaining member (2a) is detached from the bridging member (3), the bridging member (3) is able to be inserted through first and second holes disposed in the first and second sections (5a,5b) of the sleeve respectively, and thereafter, when the first retaining member (2a) is releasably attached to the bridging member (3), the first and second sections (5a,5b) of the sleeve are arranged between the first and second retaining members (2a,2b) and the first and second retaining members (2a,2b) are substantially unable to pass through the holes in the first and second sections (5a,5b) of the sleeve.
Patent SG-131128-A1 (SG)
Title: Medical syringe
Inventor: HONGO SUSUMU
IPC: A61M5/34
Filed: 2004-09-27
Abstract: A medical syringe comprising a cylindrical connection supporting member increasing the holding force of a lure inserted into a connection target. The connection supporting member is formed to be slid along the lure or a syringe body part in a state of being movable between a first position near a tip of the lure and a second position away from a tip of the lure. The syringe is characterized in that, when the connection supporting member is moved to the second position, the tip of the lure is exposed.
Patent SG-132672-A1 (SG)
Title: 1,4-disubstituted isoquinilone derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases
Inventor: FINK CYNTHIA ANNE
IPC: C07D409/14
Filed: 2004-09-23
Abstract: This invention relates to compounds of formula (I) wherein the variable substituents are described herein. The compounds are useful for the treatment of conditions and diseases characterized by an aberrant MAP kinase signaling pathway, such as cancer.
Patent SG-146498-A1 (SG)
Title: Compositions for treatment of patients with neurological disorders and cerebral infarction
Inventor: SHI XUEMIN
Filed: 2007-06-07
Abstract: COMPOSITIONS FOR TREATMENT OF PATIENTS WITH NEUROLOGICAL DISORDERS AND CEREBRAL INFARCTION The present invention provides compositions and methods for treating stroke patients using TCM and a Western medicament used for the treatment of stroke patients. (No Suitable Figure)
Patent WO-2009064257-A1 (WO)
Title: Système d'éclairage fluorescent à économie d'énergie
Inventor: HUI WING HONG
IPC: H05B41/40
Filed: 2008-08-15
Abstract: La présente invention se rapporte à des circuits à économie d'énergie permettant de réduire la consommation d'énergie d'une lampe fluorescente protégée magnétiquement. Les circuits à économie d'énergie incluent une source de tension en courant alternatif (A.C.), une paire d'interrupteurs, une paire de circuits inductifs de protection et une paire d'entrées de commande.
Patent SG-168446-A1 (SG)
Title: Supporting structure for green building facade
Inventor: YAP TIEM YEW
Filed: 2009-08-05
Abstract: There is disclosed a supporting structure 10 for mounting onto a green building facade. The supporting structure 10 comprises two sections: the first section is covered with a photovoltaic system 12 and the second section is covered with a vegetation system 14. The photovoltaic system serves to generate electrical power from sunlight to reduce energy load of the building while the vegetation system serves to cool the ambient temperature.
Patent SG-165324-A1 (SG)
Title: Compositions and methods to counteract oral malodour
Inventor: NATSCH ANDREAS
IPC: A61K8/02
Filed: 2006-08-24
Abstract: The invention relates to hedonistically pleasing oral malodour counteracting compositions including flavour compositions and oral care products, methods to form such compositions and methods to counteract oral malodour. The compositions comprise 4 or more of oral malodour counteracting actives in a total concentration of at least 20% (w/w) based on the total concentration of flavour ingredients, and an individual concentration of 1% or more per oral malodour counteractant, based on total flavour ingredients. The maximum concentration of any individual oral malodour counteracting active based on the total of oral malodour counteracting actives is 70%. The identified oral malodour counteracting actives are various flavour compounds and natural ingredients.
Patent SG-165360-A1 (SG)
Title: 2d editing metaphor for 3d graphics
Inventor: PETSCHNIGG GEORG F
Filed: 2006-09-06
Abstract: A system combines 2D and 3D modeling in rendering shapes and includes: a 3D modeling factory to generate a 3D model of selected shape parameters or features; a front face factory to generate 2D text and text effects, and some 2D shape effects; a ground plane factory to generate effects that are rendered on a ground plane of a shape; and a rasterizer/compositing engine to combine 2D and 3D effects generated by thefront face factory, ground plan factory, and the 3D modeling factory.
Patent SG-171751-A1 (SG)
Title: Compositions comprising an aryl pyrazole and/ or a formamidine methods and uses thereof
Inventor: SOLL MARK DAVID
Filed: 2009-11-13
Abstract: This invention relates to compositions for combating parasites in animals, comprising 1-arylpyrazole compounds alone or in combination with formamidine compounds. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infestation in an animal comprising administering the compositions of the invention to the animal in need thereof.
Patent SG-171825-A1 (SG)
Title: System and methods to facilitate connections to access networks
Inventor: AHMAVAARA KALLE
Filed: 2009-12-11
Abstract: The described aspects relate to methods and systems for enabling connectivity agreements between access terminals and access networks. The connectivity agreements may be established through user-side negotiations or third party negotiations for a connection with an access network. In addition, the described aspects relate to methods and systems for paying access networks for a connection.
Patent SG-172291-A1 (SG)
Title: Amide based glucagon superfamily peptide prodrugs
Inventor: DIMARCHI RICHARD D
Filed: 2009-12-18
Abstract: Prodrug formulations of glucagon superfamily peptides are provided wherein the glucagon superfamily peptide has been modified by the linkage of a dipeptide to the glucagon superfamily through an amide bond linkage. The prodrugs disclosed herein have extended half lives and are converted to the active form at physiological conditions through a non-enzymatic reaction driven by chemical instability.
Patent SG-188000-A1 (SG)
Title: A template for printing cheque with standard printer
Inventor: ZHANG WEI
Filed: 2011-08-17
Abstract: A TEMPLATE FOR PRINTING CHEQUE WITH STANDARD PRINTERAbstractA template for printing cheque with standard printer. It is made of high-temperature film that comprises of two layers — (1) top layer with (3) die cuts and (2) bottom layer. The area of the (3) die cuts on the (1) top layer are cut according to the written portion of the cheque. With the combination of the two layers (1, 2), the (1) top layer and (2) bottom layer creates a (4) pocket space between them for inserting the cheque into the template. The template is then place into the printer feeder/tray for printing with the use of software.
Patent SG-182581-A1 (SG)
Title: Visible light absorbers for ophthalmic lens materials
Inventor: LAREDO WALTER R
Filed: 2011-01-18
Abstract: Azo compounds that block visible light are disclosed. These light absorbers are particularly suitable for use in intraocular lens materials.
Patent SG-186057-A1 (SG)
Title: Mortise lock cylinder
Inventor: BUI JEANETTE VY
Filed: 2011-06-22
Abstract: A mortise lock cylinder includes a turn-piece assembly including a turn-piece in driving engagement with a first clutch. A keyed cylinder assembly includes a plug body in driving engagement with a second clutch. A first portion of the turn-piece assembly is received in the first end of a housing and a second portion of the keyed cylinder assembly is received in the second end of the housing. A cam is positioned in the cam slot and mounted for rotation. The mortise lock cylinder is configured such that the cam always is drivably engaged with the first clutch, and configured such that the second clutch is drivably coupled to the cam via the first clutch when the key is inserted into the keyed cylinder assembly.
Patent SG-188083-A1 (SG)
Title: Power headroom management in wireless communication systems
Inventor: ATHALYE SANJEEV ARVIND
Filed: 2009-01-23
Abstract: POWER HEADROOM MANAGEMENT IN WIRELESS COMMUNICATION SYSTEMSSystems and methodologies are described that facilitate power headroom management in a wireless communication system. As described herein, a predefined relationship between locations along a system frequency band and corresponding power backoff parameters is utilized to minimize spurious emissions outside the system frequency band and/or excessive interference by, for example, associating locations near one or more edges of the permitted frequency band with substantially high power backoff parameters. As further described herein, the predefined relationship can be known a priori to the base station and the mobile terminal.Figure 7
Patent SG-188557-A1 (SG)
Title: Cleaning agent having a urea content
Inventor: HAAKE MANFRED
Filed: 2011-09-16
Abstract: The invention relates to a cleaning agent for cleaning surfaces of vehicles of all types, large outdoor surface areas, in particular of buildings, plants in the food, beverage, tobacco and alcohol industries, in particular milking installations, and plants and equipment having metal, ceramic and/or plastic surfaces. Said cleaning agent contains (a) 10 to 90% of urea, (b) 5 to 70% by weight of one or more electrolytes, (c) 0.1 to 35% by weight of one or more surfactants, and (d) 0.01 to 20% by weight of one or more complexing agents. Said cleaning agent is environmentally friendly and cost-effective, extremely effective and advantageously allows the quantities of enzymes and bleaching agents used in conventional cleaning agents to be reduced. The cleaning agent contains in particular only biodegradable and/or biorenewable substances.
Patent SG-189985-A1 (SG)
Title: Inhibitors of hepatitis c virus
Inventor: ZHONG MIN
Filed: 2011-10-21
Abstract: A class of compounds that inhibit Hepatitis C Virus (HCV) is disclosed, along with compositions containing the compound, and methods of using the composition for treating individuals infected with HCV.
Patent SG-189540-A1 (SG)
Title: Biomass-derived polyester staple fibers and wet-laid nonwoven fabric formed from the same
Inventor: SHIMADA KAZUMASA
Filed: 2011-10-25
Abstract: The present invention has an object to provide staple fibers suitable for manufacturing a wet-laid nonwoven fabric having excellent adhesive strength and heat resistance at a reduced environmental burden, a manufacturing method of the same, and a nonwoven fabric using the staple fibers. The object can be achieved by polyalkylene terephthalate or polyalkylene naphthalate staple fiber wet nonwoven fabric having excellent adhesive strength and heat resistance that are provided by blending and thermal-compression bonding of low oriented yarn and fully oriented yarn, wherein a specific ratio of biomass-derived carbon, fineness, fiber length, and a weight ratio between fully oriented staple fibers and low oriented staple fibers in the wet-laid nonwoven fabric are used to obtain a fine low oriented yarn having excellent binder performance and a fine fully oriented yarn having an unprecedented level of fineness.
Patent WO-2014112954-A1 (WO)
Title: Substrat pour boîtier de semi-conducteur et méthode de formation de celui-ci
Inventor: SEN AMLAN
IPC: H01L23/31
Filed: 2014-01-21
Abstract: L'invention concerne une méthode de formation d'un substrat (10) pour boîtier de semi-conducteur et un substrat (10) pour boîtier de semi-conducteur. La méthode consiste à fournir un support (12) et former une pluralité de tampons extérieurs (14) sur le support (12), les tampons extérieurs (14) formés sur le support (12) définissant une première couche conductrice. Une opération de moulage est effectuée pour former une première couche isolante (20) sur le support (12) avec un composé de moulage (22). La première couche conductrice est intégrée dans la première couche isolante (20). Un ou plusieurs tampons d'une pluralité de tampons de liaison (30), une pluralité de traces conductrices (32) et une pluralité de microtrous (56) sont formés sur la première couche conductrice, le ou les tampons de liaison (30), les traces conductrices (32) et les microtrous (56) formés sur la première couche conductrice définissant une deuxième couche conductrice.
Patent WO-2020256639-A1 (WO)
Inventor: HIRAO ICHIRO
IPC: G01N33/569
Filed: 2020-06-18
Abstract: There is provided an aptamer for dengue virus, optionally an aptamer for dengue virus NS1 protein. The aptamer comprising at least one unnatural base, wherein the unnatural base may be 7-(2thienyl)imidazo[4,5-b]pyridine (Ds), pyrrole2-carbaldehyde (Pa) or 2-nitro-4-propynylpyrrole (Px). The aptamers of the invention may be used to identify a dengue infection in a subject. Also provided are mixtures and kits comprising the aptamer.
Patent WO-2011105972-A1 (WO)
Title: Systèmes de communication sécurisés utilisant un double masquage d'attracteurs chaotiques différents, notamment d'attracteurs chaotiques modifiés, au moyen de clés secrètes statiques-dynamiques
Inventor: SRISUCHINWONG BANLUE
IPC: H04L9/28
Filed: 2010-02-24
Abstract: L'invention concerne un système de communication sécurisé, comportant un émetteur possédant des premier et deuxième systèmes pilotes correspondant respectivement à un attracteur chaotique à cinq termes et à un attracteur chaotique de Lorenz. Un module de double masquage combine des premier et deuxième signaux de masquage chaotique correspondants à un signal message, et transmet un signal message à double masquage chaotique sur un canal public. Une clé secrète dynamique utilisant la série chronologique du premier signal de masquage chaotique est transmise sur un canal secret. Un récepteur comporte un premier système de réponse et un deuxième système de réponse constituant des homologues synchronisables des premier et deuxième systèmes pilotes. Le récepteur est relié aux canaux public et secret pour permettre les communications, et génère une version de la clé secrète dynamique qu'il soustrait du signal message à double masquage chaotique reçu. Le récepteur génère en outre une version du deuxième signal de masquage chaotique, et effectue une soustraction aux fins de récupérer un signal message. Un ensemble de clés secrètes statiques au niveau de l'émetteur et du récepteur comprend un ensemble de paramètres déterminés et de conditions initiales de chacun des attracteurs chaotiques.
Patent TN-2012000105-A1 (TN)
Title: Spirolactam derivatives and uses of same
Inventor: ZHOU HAO
IPC: A61K31/40
Filed: 2012-03-07
Abstract: The present invention provides spirolactam derivatives of formula (I): wherein R1 - R7are as defined herein; or a pharmaceutically acceptable salt thereof; and pharmaceutical compositions and uses of the same.
Patent TN-2012000449-A1 (TN)
Title: Heterocyclic compounds and their uses
Inventor: CUSHING TIMOTHY D
IPC: C07D409/12
Filed: 2012-09-18
Abstract: Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110 activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia ( T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer.
Patent TN-2012000559-A1 (TN)
Title: Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer
Inventor: BARTBERGER MICHAEL DAVID
IPC: C07D498/20
Filed: 2012-11-27
Abstract: The present invention provides MDM2 inhibitor compounds of Formula (I), wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor.
Patent TN-2017000343-A1 (TN)
Title: Cylindrical foam body, use thereof and method for producing this
Inventor: POPPE WILLY
IPC: A47C27/14
Filed: 2016-01-28
Abstract: Cylindrical foam body (1) with a central cavity (9), whereby the foam body (1) is formed by a curved flexible foam strip (2) of which two opposite ends (3) are fastened together, whereby the foam body has a height (H), whereby the strip 2 has a length (L), a height (h) and a width (b), whereby after forming the foam body (1) the longitudinal direction (L) of the strip 2 is the height direction (H) of the foam body (1), whereby the foam body (1) has an outside (5) and an inside (8), characterised in that the foam body (1) is provided on its outside (5) with two or more grooves (7) that extend over the height (H) of the foam body (1) and which only cut into the foam body (1) over a part of the distance between the outside (5) and the inside (8).
Patent WO-2005102137-A1 (WO)
Title: Mecanisme a fermeture lente pour couvercles de cuvette des w-c
Inventor: ER OSMAN
IPC: A47K13/12
Filed: 2005-04-08
Abstract: Selon cette invention, un mécanisme de fermeture lente (A) destiné aux couvercles de cuvette des W-C comprend une tige pivot gauche (1), une tige pivot droite (2), un cadre principal (3) et des pattes de montage sur la cuvette comportant des fentes (4) sur le cadre principal (3), des boîtiers d'amortissement (5), un élément de compression (6) et des convertisseurs ralentisseurs de fermeture (7); ce mécanisme permet un montage et un démontage faciles sur les couvercles des toilettes existants sans qu'aucune modification ne soit requise.
Patent WO-2011112160-A1 (WO)
Inventor: BULGUR ABDULLAH
IPC: A61K31/495
Filed: 2010-09-01
Abstract: Related to the controlled release form prepared by direct compressing using polyethylene oxide. The formulation presents a stable release profile in the pH limit of gastrointestinal system and stabilized in terms of impurities.
Patent WO-2016209187-A1 (WO)
Inventor: BEYSEL VEYSEL CELAL
IPC: G01M3/24
Filed: 2016-06-23
Abstract: La présente invention concerne un mécanisme de test de fuite comprenant un tuyau souple (41) relié à une cuve (10) depuis une première extrémité et relié à une alimentation en air (40) depuis l'autre extrémité, de façon à déterminer si une fuite de fluide vers l'extérieur se produit à travers une cuve (10) ayant un embout d'entrée d'air (11), caractérisé en ce qu'il comprend au moins un capteur de son/vibration (50) situé au voisinage de la cuve (10) et au moins une parmi les positions de contact de cuve (10) et qui détecte la vibration ou le son de la fuite dans le cas où il y a une fuite à travers la cuve (10) lorsque le côté interne de la cuve (10) est rempli d'air mis sous pression qui est au niveau décrit par la norme ; un enregistreur de données (60) relié audit capteur de son/vibration (50) ; et un terminal de traitement (70) ayant un programme de commande (71) qui compile les informations reçues en provenance de l'enregistreur de données (60) et qui calcule et délivre le résultat indiquant si la cuve (10) réussit le test de fuite ou non.